Licence variation: spironolactone for acne in women
Details
- Buyer
- NHS England
- Value
- £171,500
- Topic
- Medical equipments, pharmaceuticals and personal care products
- Published
- 5 September 2024
- Submission
- 7 October 2024
- Source
- uk:contracts_finder
Tender description
NHS England requires a supplier to apply for a major (type II) MHRA Marketing Authorisation variation for spironolactone. The variation is to add a new indication to the current licence (marketing authorisation) for treating acne in women. The Successful Supplier would need to prepare a dossier for the MHRA including a Risk Management Plan, apply for the licence variation, and if granted update their licence, Summary of Product Characteristics and patient information leaflet with the new indication and related data. To register an interest in responding to this opportunity and obtain a copy of the tender documents please go to: http://health.atamis.co.uk. All communications and Request for Information submissions will be conducted via Atamis. The portal can be accessed at any time of the day and it is free to register. Additional information: To express interest and participate in the tender, please register and apply via Atamis e-sourcing portal https://health-family.force.com/s/Welcome. Should Tenderers have any queries, or having problems using the portal, they should contact Helpdesk at: Phone: 0800 9956035 E-mail: support-health@atamis.co.uk
Timeline
- Completed: Tender published5 September 2024Current notice
- Completed: Submission date7 October 2024
About the buyer
NHS England runs the NHS in England, and buys as a central healthcare organisation with its own team of procurement professionals. Every tender is advertised on Atamis, the NHS's single eCommercial system, and larger contracts appear on Find a Tender. Much of this procurement flows through framework agreements and the Crown Commercial Service. Clinical services are commissioned directly or through the Provider Selection Regime. Seven regional teams support the commissioning of healthcare services across the country. The central commercial function that develops procurement strategy for the whole NHS sits here.
UK health spending has nearly quadrupled to £241.8bn in 2024/25, £20bn up on the year before. £140.6bn of that went to procurement, the biggest sector of UK public spending and the fastest-growing.
Over the past 5 years, most of NHS England's contract awards have been in education and training, health and social work, and IT services.
Relevant CPV codes
- 33000000 · Medical equipments, pharmaceuticals and personal care products
- 85100000 · Health services
- 85149000 · Pharmacy services
Decision makers
Connect with the people behind this procurement.
| Contact name | Job title | Phone number | Work email |
|---|---|---|---|
| Head of Procurement | +44 •••• •••••• | ••••••••@nhs-england.gov | |
| Commercial Director | +44 •••• •••••• | ••••••••@nhs-england.gov | |
| Procurement Manager | +44 •••• •••••• | ••••••••@nhs-england.gov | |
| Category Lead | +44 •••• •••••• | ••••••••@nhs-england.gov | |
| Senior Buyer | +44 •••• •••••• | ••••••••@nhs-england.gov | |
| Contracts Manager | +44 •••• •••••• | ••••••••@nhs-england.gov |
151 similar open tenders
See more open tenders related to Licence variation: spironolactone for acne in women.
- Open tender
Provision of Occupational Health Services
- Open tender
Community Specialist Stop Smoking Service
- Open tender
Progression Towards Employment
- Open tender
CA18282 - Provision of 111-2 Service
- Open tender
Provision of 111-2 Service
Related topics
Topics related to Licence variation: spironolactone for acne in women, ranked by notice volume.
- 45,138£7.7tn
Related buyers
Buyers similar to NHS England.
- 509£245.4m
- 436£15.2bn
- 418£112.6m
- 384£651.2m
- 322£24.5bn
- 298£1.7bn
- 288£3.1bn
- 279£1.2bn
- 152£1.0bn
- 150£115.2m
Win more public sector contracts
Track every UK and Ireland tender in one place — set up alerts, find decision-makers, and never miss an opportunity.
